Last Updated: September 28, 2026

Litigation Details for TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)


✉ Email this page to a colleague

« Back to Dashboard


TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

Docket 2:20-cv-05212-KM-ESK Date Filed 2020-04-28
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Kevin McNulty
Jury Demand Referred To Edward S. Kiel
Patents 6,419,960; 9,545,399; 9,844,544
Link to Docket External link to docket
Small Molecule Drugs cited in TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Details for TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-04-28 206 Opinion of five patents: United States Patent No. 9,545,399 (“the ’399 patent”), United States Patent No. 9,844,544…the ’544 patent”), United States Patent No. 9,844,545 (“the ’545 patent”), United States Patent No. 11,103,494…,494 (“the ’494 patent”), and United States Patent No. 11,103,495 (“the ’495 patent”) (collectively,…the ’399 patent; claim 37 of the ’544 patent; claims 17, 23, 24, and 28 of the ’545 patent; claim 28…the ’399 patent, claim 37 of the ’544 patent, claims 17, 23, 24, and 28 of the ’545 patent, and claim External link to document
2020-04-28 223 Opinion • U.S. Patent No. 4,996,047 (“Kelleher”) (JTX-059) • U.S. Patent No. 6,419,960 (“Krishnamurthy…of five patents: United States Patent No. 9,545,399 (“the ’399 patent”), United States Patent No. 9,844,544…the ’544 patent”), United States Patent No. 9,844,545 (“the ’545 patent”), United States Patent No. 11,103,494…,494 (“the ’494 patent”), and United States Patent No. 11,103,495 (“the ’495 patent”) (collectively,…the ’399 patent; claim 37 of the ’544 patent; claims 17, 23, 24, and 28 of the ’545 patent; claim 28 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.